written by reader DYLAN JOVINE #1 TAKEOVER TARGET FOR APRIL

by carrjp47 | April 9, 2020 12:03 pm

One small biotech Big Pharma is watching is our “#1 Takeover Target for April. Recently won an approval from FDA[1] for a certain type of cancer.
that makes it the first targeted therapy for patients with a certain type of cancer. Appears it is a targeted therapy for Leukemia.
Is there any information on this stock.

Endnotes:
  1. FDA: https://www.stockgumshoe.com/tag/fda/

Source URL: https://www.stockgumshoe.com/2020/04/microblog-dylan-jovine-1-takeover-target-for-april/


One response to “written by reader DYLAN JOVINE #1 TAKEOVER TARGET FOR APRIL”

  1. OSUfball says:

    MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in early April for its lymphoma drug and recently received a $100M investment from a foreign pharma.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.